American Oncology Network Partners with Evolent to Eliminate Prior Authorization in Cancer Care

Reuters

2025/11/07

<a href="https://laohu8.com/S/AONC">American Oncology Network</a> Partners with Evolent to Eliminate Prior Authorization in Cancer Care

American Oncology Network Inc. $(AON)$ and Evolent Health, Inc. have announced a new national partnership aimed at improving cancer care delivery. The collaboration introduces an innovative model designed to provide high-quality, more affordable, and connected cancer care without the need for prior authorization. Key components of the program include quality initiatives to enhance care across the continuum, the use of provider education and incentives, and AI-driven clinical insights powered by the MiBA data and analytics platform. Providers demonstrating adherence to quality standards will be "gold-carded," exempting them from most prior authorization requirements. The partnership also seeks to support patients through enhanced care navigation and connectivity with their oncology teams, with the model set to roll out in select markets in the coming year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2581045550"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581045550\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581045550?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 05:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581045550","market":"nz","top_or_hot":-1,"title":"American Oncology Network Partners with Evolent to Eliminate Prior Authorization in Cancer Care","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AONC\">American Oncology Network</a> Partners with Evolent to Eliminate Prior Authorization in Cancer Care\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/AONCW\">American Oncology Network</a> Inc. <a href=\"https://laohu8.com/S/AON\">$(AON)$</a> and <a href=\"https://laohu8.com/S/EVH\">Evolent Health</a>, Inc. have announced a new national partnership aimed at improving cancer care delivery. The collaboration introduces an innovative model designed to provide high-quality, more affordable, and connected cancer care without the need for prior authorization. Key components of the program include quality initiatives to enhance care across the continuum, the use of provider education and incentives, and AI-driven clinical insights powered by the MiBA data and analytics platform. Providers demonstrating adherence to quality standards will be \"gold-carded,\" exempting them from most prior authorization requirements. The partnership also seeks to support patients through enhanced care navigation and connectivity with their oncology teams, with the model set to roll out in select markets in the coming year.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>American Oncology Network Partners with Evolent to Eliminate Prior Authorization in Cancer Care</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmerican Oncology Network Partners with Evolent to Eliminate Prior Authorization in Cancer Care\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-07 05:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AONC\">American Oncology Network</a> Partners with Evolent to Eliminate Prior Authorization in Cancer Care\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/AONCW\">American Oncology Network</a> Inc. <a href=\"https://laohu8.com/S/AON\">$(AON)$</a> and <a href=\"https://laohu8.com/S/EVH\">Evolent Health</a>, Inc. have announced a new national partnership aimed at improving cancer care delivery. The collaboration introduces an innovative model designed to provide high-quality, more affordable, and connected cancer care without the need for prior authorization. Key components of the program include quality initiatives to enhance care across the continuum, the use of provider education and incentives, and AI-driven clinical insights powered by the MiBA data and analytics platform. Providers demonstrating adherence to quality standards will be \"gold-carded,\" exempting them from most prior authorization requirements. The partnership also seeks to support patients through enhanced care navigation and connectivity with their oncology teams, with the model set to roll out in select markets in the coming year.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0053671581.USD","symbol_name":"摩根大通美国小盘成长股 A(dist)","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL9lY7WP:1","article_id":"2581045550","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581045550","pubTimestamp":1762465287,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"American Oncology Network Inc.  and Evolent Health, Inc. have announced a new national partnership aimed at improving cancer care delivery. The collaboration introduces an innovative model designed to provide high-quality, more affordable, and connected cancer care without the need for prior authorization. Key components of the program include quality initiatives to enhance care across the continuum, the use of provider education and incentives, and AI-driven clinical insights powered by the MiBA data and analytics platform. Providers demonstrating adherence to quality standards will be \"gold-carded,\" exempting them from most prior authorization requirements. The partnership also seeks to support patients through enhanced care navigation and connectivity with their oncology teams, with the model set to roll out in select markets in the coming year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accu","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0053671581.USD":"摩根大通美国小盘成长股 A(dist)","EVH":"Evolent Health Inc","BK4167":"医疗保健技术","AONC":"American Oncology Network, Inc.","BK4196":"保健护理服务"},"translate_title":"美国肿瘤网络与Evolent合作取消癌症护理的事先授权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AONC":0.9,"EVH":0.9},"content_text":"American Oncology Network Partners with Evolent to Eliminate Prior Authorization in Cancer Care\n    \n\nAmerican Oncology Network Inc. $(AON)$ and Evolent Health, Inc. have announced a new national partnership aimed at improving cancer care delivery. The collaboration introduces an innovative model designed to provide high-quality, more affordable, and connected cancer care without the need for prior authorization. Key components of the program include quality initiatives to enhance care across the continuum, the use of provider education and incentives, and AI-driven clinical insights powered by the MiBA data and analytics platform. Providers demonstrating adherence to quality standards will be \"gold-carded,\" exempting them from most prior authorization requirements. The partnership also seeks to support patients through enhanced care navigation and connectivity with their oncology teams, with the model set to roll out in select markets in the coming year.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}